Literature DB >> 4031037

Aggregation of platelets by Fusobacterium necrophorum.

L J Forrester, B J Campbell, J N Berg, J T Barrett.   

Abstract

Broth cultures and washed cells of 13 of 24 bovine isolates of Fusobacterium necrophorum aggregated human platelets in platelet-rich plasma. The cell-free culture fluid was inactive. Bacteria stored at 4 degrees C in saline remained active for at least 3 months, but they did not release activity into the storage solution. Aggregation typically began within 1 min after the addition of 10(3) bacteria to 10(3) platelets was complete within 5.5 min. Assays for cytosolic lactic dehydrogenase revealed that platelet lysis did not occur. The release of [14C]serotonin from platelets preincubated with this amine accompanied aggregation, indicating that this was a typical aggregation-degranulation reaction. Platelet aggregation was inhibited by EDTA (88% at 2.0 mM), aspirin (75% inhibition at 1.0 mM), and quinacrine (80% inhibition at 0.25 mM). Thus the reaction was an ion-dependent, cyclooxygenase-sensitive event. Gel-filtered platelets were less sensitive to aggregation than were platelets in plasma, but this sensitivity was fully restored by the addition of plasma and partially restored with fibrinogen. Biotyping of the cultures revealed that none of the avirulent, B-type strains of F. necrophorum could aggregate platelets, whereas 13 of 16 virulent A type strains were positive. These results suggest that platelet aggregation by F. necrophorum is related to the virulence of this organism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031037      PMCID: PMC268368          DOI: 10.1128/jcm.22.2.245-249.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Haemagglutination inhibition and aggregation of Fusobacterium nucleatum by human salivary mucinous glycoproteins.

Authors:  W A Falkler; J R Mongiello; B W Burger
Journal:  Arch Oral Biol       Date:  1979       Impact factor: 2.633

2.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

3.  EFFECT OF STAPHYLOCOCCAL AND OTHER BACTERIAL TOXINS ON PLATELETS IN VITRO.

Authors:  A W BERNHEIMER; L L SCHWARTZ
Journal:  J Pathol Bacteriol       Date:  1965-01

4.  The reproducibility and constancy of the platelet count.

Authors:  G BRECHER; M SCHNEIDERMAN; E P CRONKITE
Journal:  Am J Clin Pathol       Date:  1953-01       Impact factor: 2.493

5.  Effects of pneumolysin on human polymorphonuclear leukocytes and platelets.

Authors:  M K Johnson; D Boese-Marrazzo; W A Pierce
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula.

Authors:  H Nygren; G Dahlén; L A Nilsson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ATP.

Authors:  H Holmsen; C A Setkowsky Dangelmaier
Journal:  Biochim Biophys Acta       Date:  1977-03-29

8.  Pathogenicity of anaerobic gram-negative rods: possible mechanisms.

Authors:  T Hofstad
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

9.  Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.

Authors:  J Hawiger; S Steckley; D Hammond; C Cheng; S Timmons; A D Glick; R M Des Prez
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

10.  Platelet aggregation by Streptococcus pyogenes.

Authors:  G E Kurpiewski; L J Forrester; B J Campbell; J T Barrett
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more
  22 in total

1.  Lemierre's Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

2.  Lemierre's syndrome, reemergence of a forgotten disease: a case report.

Authors:  Anurag Kushawaha; Muhammed Popalzai; Elie El-Charabaty; Neville Mobarakai
Journal:  Cases J       Date:  2009-03-10

3.  Disseminated intravascular coagulation with Fusobacterium necrophorum septicaemia.

Authors:  M N Potter; H C Drysdale; P A Price; A C Buck
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

Review 4.  Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures.

Authors:  Z L Tan; T G Nagaraja; M M Chengappa
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

5.  Neurologic manifestations of Fusobacterium infections in children.

Authors:  Orli Megged; Marc V Assous; Hagit Miskin; Uri Peleg; Yechiel Schlesinger
Journal:  Eur J Pediatr       Date:  2012-09-27       Impact factor: 3.183

6.  Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasin.

Authors:  M Simonet; P Triadou; C Frehel; M C Morel-Kopp; C Kaplan; P Berche
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Lemierre's syndrome: An often missed life-threatening infection.

Authors:  Narat Srivali; Patompong Ungprasert; Wonngarm Kittanamongkolchai; Nischala Ammannagari
Journal:  Indian J Crit Care Med       Date:  2014-03

8.  Genotypic diversity of anaerobic isolates from bloodstream infections.

Authors:  Keith E Simmon; Stanley Mirrett; L Barth Reller; Cathy A Petti
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

Review 9.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.